LEGEND BIOTECH
"LEGEND BIOTECH" is a word mark owned by Legend Biotech USA Inc., filed at the USPTO on December 2, 2024. It is registered and covers classes 5 and 42.
- Status
- Registered
- Since August 12, 2025
- Filed
- December 2, 2024
- Registered
- August 12, 2025
- Expires
- Not recorded
- Application no.
- 98880290
- Registration no.
- 7890671
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns LEGEND BIOTECH
The owner and representative on file with the office.
Owner
Legend Biotech USA Inc.
Bridgewater, United States
Representative
Preetha Chakrabarti
Crowell & Moring LLP
What the mark covers
The products and services LEGEND BIOTECH is filed for, grouped by Nice class.
Pharmaceuticals and medical preparations for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical use; biological preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; chemical preparations for pharmaceutical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; drugs for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; immunostimulants; medicines for human purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceutical preparations, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; Pharmaceutical compositions for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; stem cells for medical purposes; Injectable pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; anti-cancer drugs; Anti-cancer preparations; Compounds for treating cancer; Pharmaceutical preparations and substances for the treatment of cancer; Anti-cancer preparations from hormones and antagonists; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Cell growth media for growing cells for medical use; Cells for medical use, Living cells for medical use; vaccine preparation; Medical diagnostic preparations
Scientific and technological services, namely, scientific research, analysis, and testing in the field of biotechnology and scientific research and design relating thereto; design and development of computer hardware and software; biological research; chemical analysis; chemical research; chemistry services namely research in the field of chemistry; Scientific research in the nature of conducting clinical trials for others; culturing of cells for scientific research purposes, for others; medical research; research and development of new products for others; scientific laboratory services; scientific research; technological research in the field of biotechnology; Cell separation technology research services; Cell separation research services; Cell culture services for scientific and research purposes, for others; Scientific services relating to the isolation and cultivation of human tissues and cells for scientific and research purposes; Scientific research for medical purposes in the area of cancerous diseases; Stem cell research services; Antibody research and development; Pharmaceutical research and development; Medical computer programming
What has happened so far
Steps recorded by the USPTO, newest first.
- Teas change of correspondence received
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Applicant/correspondence changes (non-responsive) entered
- Teas change of owner address received
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
4 earlier steps on the official record.
About LEGEND BIOTECH
Who owns the trademark "LEGEND BIOTECH"?
The USPTO trademark "LEGEND BIOTECH" (application 98880290) is owned by Legend Biotech USA Inc.
What is the status of "LEGEND BIOTECH"?
Its status at the USPTO is: registered.
When was "LEGEND BIOTECH" registered?
It was registered on August 12, 2025.
Get this data via the API
Everything on this page comes from the Signa API. Pull LEGEND BIOTECH and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a25-d416-73ac-bc89-2ff5fcc62d7c
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a25-d416-73ac-bc89-2ff5fcc62d7c",
"object": "trademark",
"mark_text": "LEGEND BIOTECH",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "98880290",
"filing_date": "2024-12-02",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "LEGEND BIOTECH USA INC.",
"entity_id": null
}
]
}